Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.

Breast Cancer Res · 2017 · PMC5545026 · PMID 28778177

Europe PMC DOI

hedged sentence

0.0090

closest p · 0.2× alpha

0.0090

boldest claim

The sentences

highly significantP = 0.009actually significant

This was more highly significant over the final two treatment days ( P = 0.009), when post hoc testing showed the increase in tumor size in mice receiving combination therapy was significantly less than that in control mice ( P = 0.032), whereas there was no difference between control mice and those receiving either monotherapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.